Illumina

NASDAQ
ILMN
Stock
Yield per half year: +39.97%
Dividend yield: 0%
Sector: Healthcare

99.66 $

0 $ 0%
70.3 $
155.15 $

Min/max per year

Share chart Illumina

Main settings

Currency
usd
IPO Time
2000-07-28
ISIN
US4523271090
Industry
Life Sciences Tools & Services
Report Currency
usd
Sector
Health Care
Website

Grade

Underestimation
Title Value Grade
P/S 4.86 3
P/BV 8.95 1
P/E -12.66 0
Efficiency
Title Value Grade
ROA -14.9 0
ROE -30.13 0
ROIC 6.96 2
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA -3.62 10
Debt/Ratio 0.416 10
Debt/Equity 1.66 7
Growth impulse
Title Value Grade
Revenue, bln, % 34.94 5
Ebitda, % -225 0
EPS, % -273.63 0

Dividends

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 99.66 $ 0 $ 0 $ 0 % 0 % 0 %
Week 99.29 $ 0 $ 0 $ +0.3726 % 0 % 0 %
Month 98.44 $ 94.56 $ 101.8 $ +1.24 % 0 % 0 %
Three month 90.49 $ 82.66 $ 109.88 $ +10.13 % 0 % 0 %
Half a year 71.2 $ 70.3 $ 109.88 $ +39.97 % 0 % 0 %
Year 141.09 $ 70.3 $ 155.15 $ -29.36 % 0 % 0 %
3 years 199.93 $ 70.3 $ 245.45 $ -50.15 % 0 % 0 %
5 years 398.62 $ 70.3 $ 524.84 $ -75 % 0 % 0 %
10 years 167.72 $ 70.3 $ 524.84 $ -40.58 % 0 % 0 %
Year to date 88.74 $ 70.3 $ 144.22 $ +12.31 % 0 % 0 %

Insider trading

Main owners

Contained in ETF

ETF
Share, %
Profitability for 1 year, %
Commission, %
Global X Telemedicine & Digital Health ETF Registered 4.01425 -1.15 0.68
Future Tech ETF 2.02764 479.5 0.35
Principal Healthcare Innovators ETF 2.02764 -3.92 0.35
IQ Engender Equality ETF 1.49781 1.27 0.45
Pacer BioThreat Strategy ETF 0.71622 -0.0037 0.7
Syntax Stratified MidCap ETF 0.45703 -0.3413 0.35
iShares Morningstar Mid-Cap Growth ETF 0.38685 401.43 0.06
iShares Morningstar Mid-Cap ETF 0.19271 228.42 0.04
Nationwide Nasdaq-100 Risk-Managed Income ETF 0.14325 4.81 0.68
iShares Morningstar Large-Cap Growth ETF 0.08548 233.44 0.04
iShares Morningstar Large-Cap ETF 0.04135 176.91 0.03
JPMorgan U.S. Aggregate Bond ETF 0.03 2.7 0.07
Columbia U.S. ESG Equity Income ETF 0.02743 -2.44 0.35
0.9116.970.32

Similar companies



Company management

Head Job title Payment Year of birth
Stephanie Campos President N/A
Mr. Charles E. Dadswell Esq. Senior VP & General Counsel 1.06M 1959 (66 years)
Ms. Carissa L. Rollins Chief Information Officer N/A 1970 (55 years)
Dr. Steven Barnard Ph.D. Chief Technology Officer N/A
Ms. Sallilyn Schwartz Vice President of Investor Relations N/A
Mr. Jacob Thaysen Ph.D. CEO & Director N/A 1975 (50 years)
Mr. Ankur Dhingra Chief Financial Officer 1976 (49 years)
Mr. Kevin Carl Pegels Chief of Global Operations 1968 (57 years)
Mr. Scott Ericksen VP & Chief Accounting Officer 1973 (52 years)
Mr. Jakob Wedel Chief Strategy & Corporate Development Officer and CEO Chief of Staff

About company

Address: United States, San Diego, 5200 Illumina Way - Open in google maps, Open in yandex maps
Website: http://www.illumina.com

About Illumina

Компания Illumina, Inc., основана в апреле 1998 года, занимается разработкой, производством и внедрением систем анализа генетического разнообразия и биологических функций. Illumina производит линейку продуктов и услуг для секвенирования, генотипирования и изучения экспрессии генов.